SCHEMBL29198301

SCHEMBL29198301

CC(C)(C)OC(=O)N1CCC(n2c(=O)[nH]c3c(-n4cncn4)cccc32)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.48
CCR5 P51681 2/20 0.44
HSD11B1 P28845 4/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
HCAR1 Q9BXC0 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
PRKCG P05129 1/20 0.40
PRKCB P05771 1/20 0.40
PRKCA P17252 1/20 0.40
PRKCH P24723 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCD Q05655 1/20 0.40
CALCRL Q16602 2/20 0.40
CTSD P07339 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28516319 0.87 GPR119 (0.49) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL29198229 0.85 CCR5 (0.43) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL22605720 0.82 USP30 (0.50) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL28510485 0.81 HSD11B1 (0.61) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL28511175 0.81 CCR5 (0.50) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL28511191 0.81 OPRM1 (0.38) HSD11B1CHRM1OPRM1CALCRLPARP1
SCHEMBL4234708 0.81 DRD2 (0.52) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL29198263 0.81 CCR5 (0.49) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL3246870 0.81 OPRM1 (0.55) GPR119CCR5HSD11B1CHRM2CHRM4
SCHEMBL28501201 0.81 HSD11B1 (0.50) GPR119CCR5HSD11B1CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074511-B Substituted benzodiazoles and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-04-26 CN disclosed